Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Update

Mangoceuticals, Inc. (NASDAQ:MGRX) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 244,900 shares, a growth of 237.3% from the March 15th total of 72,600 shares. Based on an average daily volume of 157,300 shares, the days-to-cover ratio is currently 1.6 days. Approximately 7.1% of the company’s stock are short sold.

Mangoceuticals Price Performance

Shares of NASDAQ MGRX opened at $1.82 on Tuesday. The business has a 50-day moving average of $3.56 and a 200-day moving average of $7.29. The stock has a market capitalization of $9.41 million, a price-to-earnings ratio of -0.31 and a beta of 2.41. Mangoceuticals has a fifty-two week low of $1.49 and a fifty-two week high of $16.80.

Mangoceuticals (NASDAQ:MGRX) last announced its quarterly earnings results on Thursday, March 20th. The company reported ($1.01) EPS for the quarter. Mangoceuticals had a negative net margin of 1,237.00% and a negative return on equity of 138.00%. The firm had revenue of $0.11 million during the quarter.

About Mangoceuticals

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.